e-Lung CT Biomarker Stratifies Patients at Risk of IPF Progression in a 52-Week Clinical Trial

Am J Respir Crit Care Med. 2024 Feb 16. doi: 10.1164/rccm.202312-2274LE. Online ahead of print.NO ABSTRACTPMID:38363798 | DOI:10.1164/rccm.202312-2274LE

Source: Am J Respir Crit Car... - February 16, 2024 Category: Intensive Care Authors: Anand Devaraj Finja Ottink Christian Rennison-Jones Fran çois-Xavier Blé Olivier Joly Adnan Azim Stephen Gerry George Harston Kristoffer Ostridge Peter M George Source Type: research